4,4,5,5, tetrasubstituted imidazolines
US7851626B2 · kind B2 · utility
40Cited by
2References
33Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 27, 2006 |
| Grant date | Dec 14, 2010 |
| Priority date | — |
| Expiry date | Jun 17, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
There is provided a compound of formula Iand the pharmaceutically acceptable salts and esters thereofwherein X1, X2, R1, R2, R3, R4, R5 and R6 are herein described.The compounds exhibit activity as anticancer agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.